Evaluation of the IMMY ALPHA Histoplasma Antigen Enzyme Immunoassay for Diagnosis of Histoplasmosis Marked by Antigenuria
Author(s) -
Ann M. LeMonte,
Lindsey Egan,
Patricia Connolly,
Michelle Durkin,
L. Joseph Wheat
Publication year - 2007
Publication title -
clinical and vaccine immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.649
H-Index - 77
eISSN - 1556-6811
pISSN - 1556-679X
DOI - 10.1128/cvi.00035-07
Subject(s) - histoplasmosis , immunoassay , histoplasma , antigen , enzyme , virology , alpha (finance) , immunology , histoplasma capsulatum , microbiology and biotechnology , medicine , chemistry , antibody , biology , biochemistry , cronbach's alpha , clinical psychology , psychometrics
The sensitivity of detection of antigenuria in patients positive by the MiraVista Diagnostics Histoplasma enzyme immunoassay (MVD EIA) was 44% with the IMMY ALPHA Histoplasma antigen EIA. The specificity was 84% with the IMMY EIA versus 98% with the MVD EIA. The correlation between assays for positive cases was weak (r(2) = 0.430).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom